Volume 15 - Issue 1, 2015 - Technology Update

Screening with Breast Tomosynthesis : An Emerging Reality

The amount of clinical proof for the efficacy of Tomosynthesis in screening is significantly larger the proof available in the early days of the transition from analogue mammography to FFDM. Results from studies in Europe using Tomosynthesis in population based screening and results from screening with Tomosynthesis in the USA are concordant around an increase in invasive cancer detective and a reduction in recall rates. As screening programs begins the adoption of Tomosynthesis many questions arise around the practical implementation of the technology; however, current literature is primarily focused around the clinical results. Presenters at the symposium will share their experiences with the challenges, the solutions and the early results from implementing Tomosynthesis in primary screening for breast cancer.

 

Moderator for session:

Prof.emer.Per Skaane

 

Speakers/Presentations:

Sarah M. Friedewald, MD. Chicago, USA

The American Experience

 

Dra. Marina  Alvarez Benito / Dra. Sara Romero.

Cordoba, Espana

The Spanish Experience

 

Dott.ssa Daniela Bernardi. Trento, Italia

The Italian Experience

 

Prof.emer. Per Skaane. Oslo, Norge

The Norwegian experience 

Print as PDF
Theamount of clinical proof for the efficacy of Tomosynthesis in screening is significantlylarger the proof available in the early days of the transition f

No comment


Please login to leave a comment...